Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies

Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

2 new

Companies with a Value score of at least 3, ordered by Value score

95 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
6160 BeiGene	HK$104.70	-3.4%	1.5%	HK$18.8b	HK$166.64	PS5.8x	E73.3%	n/a
512 Grand Pharmaceutical Group	HK$4.74	1.3%	22.8%	HK$16.6b	HK$5.80	PE6.9x	E2.3%	5.5%
1801 Innovent Biologics	HK$35.20	-5.9%	-8.1%	HK$57.7b	HK$54.01	PS7.3x	E56.0%	n/a
1681 Consun Pharmaceutical Group	HK$7.79	-0.1%	66.5%	HK$6.5b	HK$10.20	PE7.3x	E14.7%	7.4%
1530 3SBio	HK$6.05	-1.6%	-9.0%	HK$14.2b	HK$8.23	PE8.1x	E16.4%	4.0%
2877 China Shineway Pharmaceutical Group	HK$9.36	-8.9%	n/a	HK$7.1b	HK$12.88	PE6x	E8.1%	6.0%
2877 China Shineway Pharmaceutical Group	HK$9.36	-8.9%	n/a	HK$7.1b	HK$12.88	PE6x	E8.1%	6.0%
9995 RemeGen	HK$14.76	-7.4%	-55.6%	HK$14.8b	HK$24.97	PS4.9x	E54.9%	n/a
9995 RemeGen	HK$14.76	-7.4%	-55.6%	HK$14.8b	HK$24.97	PS4.9x	E54.9%	n/a
2126 JW (Cayman) Therapeutics	HK$1.28	-3.8%	-42.9%	HK$517.9m	HK$2.40	PS2.8x	E-1.8%	n/a
3933 United Laboratories International Holdings	HK$11.30	-4.7%	72.0%	HK$20.5b	HK$12.09	PE6.6x	E5.0%	5.2%
512 Grand Pharmaceutical Group	HK$4.74	1.3%	22.8%	HK$16.6b	HK$5.80	PE6.9x	E2.3%	5.5%
1801 Innovent Biologics	HK$35.20	-5.9%	-8.1%	HK$57.7b	HK$54.01	PS7.3x	E56.0%	n/a
3933 United Laboratories International Holdings	HK$11.30	-4.7%	72.0%	HK$20.5b	HK$12.09	PE6.6x	E5.0%	5.2%
1530 3SBio	HK$6.05	-1.6%	-9.0%	HK$14.2b	HK$8.23	PE8.1x	E16.4%	4.0%
1801 Innovent Biologics	HK$35.20	-5.9%	-8.1%	HK$57.7b	HK$54.01	PS7.3x	E56.0%	n/a
2877 China Shineway Pharmaceutical Group	HK$9.36	-8.9%	38.7%	HK$7.1b	HK$12.88	PE6x	E8.1%	6.0%
512 Grand Pharmaceutical Group	HK$4.74	1.3%	22.8%	HK$16.6b	HK$5.80	PE6.9x	E2.3%	5.5%
9995 RemeGen	HK$14.76	-7.4%	-55.6%	HK$14.8b	HK$24.97	PS4.9x	E54.9%	n/a
6160 BeiGene	HK$104.70	-3.4%	1.5%	HK$18.8b	HK$166.64	PS5.8x	E73.3%	n/a
1530 3SBio	HK$6.05	-1.6%	-9.0%	HK$14.2b	HK$8.23	PE8.1x	E16.4%	4.0%
6160 BeiGene	HK$104.70	-3.4%	1.5%	HK$18.8b	HK$166.64	PS5.8x	E73.3%	n/a
3933 United Laboratories International Holdings	HK$11.30	-4.7%	72.0%	HK$20.5b	HK$12.09	PE6.6x	E5.0%	5.2%
2142 HBM Holdings	HK$1.34	15.5%	-14.6%	HK$981.5m	n/a	PE5.9x	n/a	n/a

Page 1 of 4